This content is from: Patents

Dissent in PTAB edict could spur surge of Arthrex-extension bids

Stakeholders could try to use Judge Pauline Newman’s dissent in Mobility Workx to extend USPTO director review to PTAB institution decisions, say sources

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial